Synonyms
FLJ43280 antibody, TATDN1 antibody, hepatocarcinoma high expression protein antibody, putative deoxyribonuclease TATDN1 antibody, TatD DNase domain containing 1 antibody
Specificity
Format
Product Type
Primary antibody
Formulation
0.1M Tris, 0.1M Glycine, 10% Glycerol (pH7). 0.01% Thimerosal was added as a preservative.
Calculated Molecular Weight
34 kDa
Immunogen
Recombinant fragment corresponding to a region within amino acids 1 and 199 of TATDN1 (Uniprot ID# Q6P1N9)
Applications
Applications Tested
ICC/IF,Western blot
Application Notes
Suggested starting dilutions are as follows: WB: 1:500-1:3000, ICC/IF: 1:100-1:1000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.

TATDN1 antibody [N1C2] detects TATDN1 protein at cytosol on human ovarian carcinoma by immunohistochemical analysis.
Sample: TATDN1 antibody [N1C2] (107-10649) dilution: 1:250.

Immunofluorescence analysis of paraformaldehyde-fixed HeLa, using TATDN1(107-10649) antibody at 1:200 dilution.

Sample(30 ug whole cell lysate)
A:293T
B:A431
C:MOLT4
12% SDS PAGE
107-10649 diluted at 1:1000
Storage
Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
Expiration:
12 months from the date of shipment when stored properly.